Principal Financial Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $91.5K | Sell |
|
|||||
|
2023
Q4 | $208K | Buy |
|
|||||
|
2023
Q3 | $132K | Buy |
|
|||||
|
2023
Q2 | $129K | Sell |
|
|||||
|
2023
Q1 | $152K | Sell |
|
|||||
|
2022
Q4 | $199K | Buy |
|
|||||
|
2022
Q3 | $53K | Sell |
|
|||||
|
2022
Q2 | $52K | Sell |
|
|||||
|
2022
Q1 | $152K | Buy |
|
|||||
|
2021
Q4 | $131K | Sell |
|
|||||
|
2021
Q3 | $252K | Buy |
|
|||||
|
2021
Q2 | $288K | Sell |
|
|||||
|
2021
Q1 | $255K | Sell |
|
|||||
|
2020
Q4 | $273K | Sell |
|
|||||
|
2020
Q3 | $524K | Buy |
|
|||||
|
2020
Q2 | $269K | Buy |
|
|||||
|
2020
Q1 | $74K | Sell |
|
|||||
|
2019
Q4 | $102K | Sell |
|
|||||
|
2019
Q3 | $95K | Buy |
|
|||||
|
2019
Q2 | $119K | Sell |
|
|||||
|
2019
Q1 | $121K | Sell |
|
|||||
|
2018
Q4 | $109K | Sell |
|
|||||
|
2018
Q3 | $168K | Buy |
|
|||||
|
2018
Q2 | $130K | Buy |
|
|||||
|
2018
Q1 | $72K | Buy |
|
|||||
|
2017
Q4 | $74K | Hold |
|
|||||
|
2017
Q3 | $49K | Sell |
|
|||||
|
2017
Q2 | $62K | Buy |
|
|||||
|
2017
Q1 | $72K | Buy |
|
|||||
|
2016
Q4 | $43K | Buy |
|
|||||
|
2016
Q3 | $61K | Hold |
|
|||||
|
2016
Q2 | $37K | Buy |
|
|||||
|
2016
Q1 | $31K | Hold |
|
|||||
|
2015
Q4 | $45K | Hold |
|
|||||
|
2015
Q3 | $37K | Sell |
|
|||||
|
2015
Q2 | $76K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $57K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $134K | Buy |
|